Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A.

Eur Urol. 2007 Jan;51(1):199-203; discussion 204-6. Epub 2006 Jun 14.

PMID:
16806666
2.

Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.

Cathcart P, van der Meulen J, Armitage J, Emberton M.

J Urol. 2006 Jul;176(1):200-4; discussion 204.

PMID:
16753401
3.

BPH: epidemiology and comorbidities.

McVary KT.

Am J Manag Care. 2006 Apr;12(5 Suppl):S122-8. Review.

4.
5.
6.
7.

Low incidence of acute urinary retention in the general male population: the triumph project.

Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC.

Eur Urol. 2005 Apr;47(4):494-8. Epub 2005 Jan 15.

PMID:
15774248
8.

Association of hypertension with symptoms of benign prostatic hyperplasia.

Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M.

J Urol. 2004 Oct;172(4 Pt 1):1390-3.

PMID:
15371852
9.

Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.

McNeill SA, Hargreave TB; Members of the Alfaur Study Group.

J Urol. 2004 Jun;171(6 Pt 1):2316-20.

PMID:
15126812
10.

Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.

Manikandan R, Srirangam SJ, O'Reilly PH, Collins GN.

BJU Int. 2004 Jan;93(1):84-8.

PMID:
14678374
12.

Use of comorbidity scores for control of confounding in studies using administrative databases.

Schneeweiss S, Maclure M.

Int J Epidemiol. 2000 Oct;29(5):891-8. Review.

PMID:
11034974
13.

Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.

Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R, Kandzari S, Herlihy R, Kornitzer G, Brown BT, Holtgrewe HL, Taylor A, Wang D, Waldstreicher J.

Eur Urol. 2000 May;37(5):528-36.

PMID:
10765090
14.

Incidence rates and risk factors for acute urinary retention: the health professionals followup study.

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.

J Urol. 1999 Aug;162(2):376-82.

PMID:
10411042
15.

The management of men with acute urinary retention. National Prostatectomy Audit Steering Group.

Pickard R, Emberton M, Neal DE.

Br J Urol. 1998 May;81(5):712-20.

PMID:
9634047
16.

Natural history of prostatism: risk factors for acute urinary retention.

Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM.

J Urol. 1997 Aug;158(2):481-7.

PMID:
9224329
17.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

Romano PS, Roos LL, Jollis JG.

J Clin Epidemiol. 1993 Oct;46(10):1075-9; discussion 1081-90. No abstract available.

PMID:
8410092
18.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Charlson ME, Pompei P, Ales KL, MacKenzie CR.

J Chronic Dis. 1987;40(5):373-83.

PMID:
3558716
19.

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Breslow NE, Day NE.

IARC Sci Publ. 1987;(82):1-406. Review. No abstract available.

PMID:
3329634

Supplemental Content

Support Center